Equity strategies

Carmignac Portfolio Grandchildren

Luxembourg SICAV sub-fundGlobal marketSRI Fund Article 9
Share Class

LU2427320739

An intergenerational Fund focused on quality, sustainable companies
  • A Fund focused on selecting high-quality companies around the world, with sound financials and sustainable profitability.
  • An investment process based on rigorous fundamental analysis, quantitative screening, and a socially responsible investment approach.
  • A concentrated, low turnover portfolio of high-conviction names seeking to provide steady growth of your capital over the long term.
Key documents
Asset Allocation
Equities97.1 %
Other2.9 %
Data as of:  30 Apr 2025.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 7.0 %
-
-
+ 30.6 %
- 2.0 %
From 31/12/2021
To 07/05/2025
Calendar Year Performance 2024
-
-
-
-
-
-
-
- 19.5 %
+ 20.7 %
+ 16.7 %
Net Asset Value
102.23 £
Asset Under Management
492 M €
Net Equity Exposure30/04/2025
97.1 %
SFDR - Fund Classification

Article

9
Data as of:  7 May 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.

Carmignac Portfolio Grandchildren fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  30 Apr 2025.
Fund management team
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager
[Management Team] [Author] Ejikeme Obe

Obe Ejikeme

Fund Manager, Analyst

Market environment

  • April 2025 was characterized by notable volatility in the financial markets, marked by a sharp correction followed by an equivalent rebound, resulting in relatively minor final variations.- The month commenced with an announcement from Donald Trump concerning higher tariffs than the markets had anticipated. This "Liberation Day," as the US president termed it, created recession fears among investors, triggering a crisis of confidence and causing a flight from risky assets and US assets, including the dollar and Treasury bonds.
  • In response to the sharp market downturn, Trump suspended most of the tariff measures for 90 days, excluding China, which allowed equities to rebound.
  • European and emerging market equities continued to outperform their US counterparts. Gold was the standout winner of the month, in stark contrast to oil, which experienced a significant decline.
  • On the macroeconomic front, uncertainty surrounding trade barriers began to negatively impact leading US activity indicators, such as consumer sentiment.
  • The earnings season started robustly, yet companies expressed caution about the future due to ongoing tariff-related uncertainties.

Performance commentary

• In April, the Fund experienced a negative absolute performance, although it outperformed its benchmark.• This outperformance was primarily driven by our active management and strategic stock selection in the Consumer sector. • The main detractors for the month were stocks in the Healthcare and Consumer Discretionary sectors. • Thermo Fisher was the most significant detractor, as the newly imposed tariffs increased the costs of parts and subassemblies sourced from China, thereby affecting the company's margins. • Similar to Thermo Fisher, Amazon also felt the impact of tariffs, particularly those related to U.S.-China trade, which increased its operational costs and affected profitability. • Our exposure to the Industrials and Technology sectors contributed positively to our relative performance. • ServiceNow surged over 10% after reporting impressive financial results for the first quarter of 2025, with subscription revenues rising by nearly 20%. • In the Industrials sector, Comfort Systems demonstrated strong performance following their report of an increased backlog, indicating robust future demand and a healthy pipeline of projects.

Outlook strategy

• Our macroeconomic framework continues to advocate for a defensive approach to equity markets.• During the month, we made some adjustments to our portfolio by initiating a new position in the Fund. • We started positions in Unilever, a British multinational consumer goods company known for its wide range of food, personal care, and household products which is expected to perform well in uncertain market conditions. • Amid the market downturn in the beginning of April, we reinforced positions that suffered the most, such as Nvidia as their valuations appear highly attractive and they continue to have massive demand from tech giants. • Additionally, we increased our position in Servicenow prior to their earnings. • We continued to build our positions in the two US drug distributors, Cencora and McKesson, which we initiated last month and have shown consistent growth.

Performance Overview

Data as of:  7 May 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 09/05/2025

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  30 Apr 2025.
Equity Investment Weight97.1 %
Net Equity Exposure97.1 %
Number of Equity Issuers48
Active Share79.4 %

Carmignac Portfolio Grandchildren Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  30 Apr 2025.
North America67.5 %
Europe32.5 %
View details

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Managers.
Fund Management Team
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager
[Management Team] [Author] Ejikeme Obe

Obe Ejikeme

Fund Manager, Analyst
Carmignac Portfolio Grandchildren is an intergenerational Fund that focuses on high-quality companies to help investors build capital not only for themselves, but also for future generations.
[Management Team] [Author] Denham Mark

Mark Denham

Head of Equities, Fund Manager
View Fund's characteristics

Related articles

Global equities16 April 2025English

FP Carmignac Global Equity Compounders: Letter from the Fund Managers

3 minute(s) read
Find out more
Global equities11 March 2025English

Software-As-A-Compounder

Find out more
Events6 February 2025English

Annual Meeting 2025

Speakers : Raphaël Gallardo, Mark Denham
1 minute(s) read
Find out more
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
​The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.